| 1 |
33995076 | Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes. | 2021 |
1 |
| 2 |
33008919 | Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity. | 2020 Dec |
1 |
| 3 |
29172026 | Effect of non-prohibited drugs on the phase II metabolic profile of morphine. An in vitro investigation for doping control purposes. | 2018 Jun |
1 |
| 4 |
28552915 | The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants. | 2017 Aug |
2 |
| 5 |
26802129 | Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo. | 2016 Apr |
1 |
| 6 |
25496264 | Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7. | 2015 Apr |
1 |
| 7 |
25249502 | Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation. | 2014 Nov |
1 |
| 8 |
23670235 | Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. | 2013 Jul |
1 |
| 9 |
21438849 | Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone. | 2011 Jul |
1 |
| 10 |
21780761 | Characterization of dibenzo[a,l]pyrene-trans-11,12-diol (dibenzo[def,p]chrysene) glucuronidation by UDP-glucuronosyltransferases. | 2011 Sep 19 |
1 |
| 11 |
20145913 | Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies. | 2010 Mar |
1 |
| 12 |
20713656 | Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7. | 2010 Nov |
1 |
| 13 |
18098064 | Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. | 2008 Jan |
1 |
| 14 |
17339869 | The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. | 2007 Mar |
1 |
| 15 |
17446261 | Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. | 2007 Jul |
1 |
| 16 |
14744946 | Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol. | 2004 Feb |
1 |
| 17 |
14575648 | Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. | 2003 Nov 1 |
1 |
| 18 |
12185559 | Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. | 2002 Aug |
1 |
| 19 |
11302935 | Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. | 2001 May |
1 |
| 20 |
10529008 | Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. | 1999 Jul-Aug |
1 |